CRIS Current Research Information System

ARPINATI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.457
EU - Europa 1.823
AS - Asia 782
AF - Africa 112
SA - Sud America 5
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.448
IT - Italia 487
GB - Regno Unito 341
SE - Svezia 295
CN - Cina 255
SG - Singapore 249
DE - Germania 201
IN - India 102
VN - Vietnam 89
IE - Irlanda 85
UA - Ucraina 73
RU - Federazione Russa 55
AT - Austria 54
TG - Togo 50
FI - Finlandia 47
FR - Francia 43
BG - Bulgaria 38
JO - Giordania 36
EE - Estonia 23
ZA - Sudafrica 21
CI - Costa d'Avorio 20
CH - Svizzera 18
NL - Olanda 18
BE - Belgio 14
NG - Nigeria 14
JP - Giappone 10
CA - Canada 9
ID - Indonesia 8
IR - Iran 8
TR - Turchia 6
SC - Seychelles 5
HR - Croazia 4
PK - Pakistan 4
AU - Australia 3
CL - Cile 3
CZ - Repubblica Ceca 3
ES - Italia 3
KR - Corea 3
LT - Lituania 3
NO - Norvegia 3
BD - Bangladesh 2
DK - Danimarca 2
HU - Ungheria 2
KE - Kenya 2
PL - Polonia 2
RS - Serbia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BR - Brasile 1
EC - Ecuador 1
GR - Grecia 1
HK - Hong Kong 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 5.183
Salva come PNG Salva come JPEG
Città #
Chandler 319
Southend 301
Fairfield 266
Singapore 224
Ashburn 167
Bologna 143
Woodbridge 125
Houston 117
Ann Arbor 115
Wilmington 113
Seattle 112
Princeton 87
Dublin 85
Cambridge 79
Santa Clara 75
New York 61
Boardman 59
Dong Ket 55
Lomé 50
Helsinki 46
Jacksonville 46
Sofia 38
Vienna 38
Amman 36
Nanjing 36
Bremen 34
Westminster 32
Milan 29
Florence 27
Padova 24
Berlin 23
Beijing 22
Turin 22
Abidjan 20
San Diego 20
Falls Church 17
Redmond 16
Saint Petersburg 16
Rome 15
Abeokuta 14
Bern 14
Brussels 14
Los Angeles 13
Redwood City 12
Pune 10
Tokyo 10
Hangzhou 9
Jinan 9
Medford 9
Mülheim 9
Shenyang 9
Changsha 8
Des Moines 8
Hebei 8
Hyderabad 8
Jakarta 8
Toronto 8
Washington 8
Nanchang 7
Tianjin 7
Guangzhou 6
Haikou 6
Phoenix 6
Amsterdam 5
Bari 5
Jiaxing 5
Kunming 5
Mountain View 5
Ravenna 5
Reggio Emilia 5
San Francisco 5
Taiyuan 5
Taizhou 5
York 5
Zhengzhou 5
Andover 4
Boydton 4
Forlì 4
Genoa 4
London 4
Mahé 4
Meda 4
Ningbo 4
Olalla 4
Osimo 4
Sacramento 4
Shanghai 4
Shenzhen 4
Assisi 3
Buffalo 3
Calderara di Reno 3
Dehradun 3
Falkenstein 3
Fremont 3
Fuzhou 3
Kolkata 3
Lanzhou 3
Modena 3
Moscow 3
Oslo 3
Totale 3.478
Salva come PNG Salva come JPEG
Nome #
Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. 256
Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation 184
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 159
Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. 158
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group. 154
Successful treatment of severe hemorrhagic cystitis with selective vesical artery embolization. 150
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). 148
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 144
Developing a new grading system of ocular surface disease after allogeneic hematopoietic stem cell transplantation (HSCT). 134
Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye 129
In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. 126
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 126
Hairy Cell Leukemia: Allogeneic Transplantation Could be an Optimal Option in Selected Patients. 125
Follicle features in adolescent and young adult women with Hodgkin's disease prior to chemotherapy: a preliminary report. 125
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice 123
Eyelid metrics assessment in patients with chronic ocular graft versus-host disease 123
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 120
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis 117
Meibomian Gland Dropout in Hematological Patients Before Hematopoietic Stem Cell Transplantation 117
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? 115
In vitro growth and differentiation of human dental pulp derived multipotent mesenchymal stem cells. 112
Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease. 111
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 111
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 107
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 106
Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study. 102
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 102
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 92
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 90
Validation of the New European LeukemiaNet (ELN) Recommendations for Bcr-Abl Kinase Domain Mutation Analysis In Chronic Myeloid Leukemia: An Analysis of the GIMEMA CML Working Party Studies 90
null 86
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukaemia 84
Meibomian Gland Dropout in Hematological Patients Prior to Hematopoietic Stem Cell Transplantation 83
null 83
null 75
Score predittivo di dry eye in corso di CGVHD dopo trapianto allogenico con cellule staminali emopoietiche 73
Transfusion-related Listeria monocytogenes infection in a patient with acute myeloid leukaemia 73
Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study 73
Longitudinal tear protein changes correlate with ocular chronic gvhd development in allogeneic hematopoietic stem cell transplant patients 73
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 73
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 66
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 61
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 61
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 60
Dry Eye Disease Is Already Present in Hematological Patients before Hematopoietic Stem Cell Transplantation 57
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 54
Incidence, Risk Factors and Complications of Ocular Graft-Versus-Host Disease Following Hematopoietic Stem Cell Transplantation 54
Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study 51
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 49
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation 46
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 42
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT) 36
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 34
Sequence and expression analysis of the β-2-microglobulin gene in dialysis patients 12
Epigenetic age acceleration in hematopoietic stem cell transplantation 11
Totale 5.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020524 0 0 0 0 0 0 115 132 121 64 47 45
2020/2021477 99 34 13 15 21 29 8 33 43 41 30 111
2021/20221.003 59 24 55 118 67 45 32 75 59 115 233 121
2022/20231.371 144 179 76 177 108 99 38 74 233 24 143 76
2023/2024494 38 63 35 49 43 136 20 23 16 21 34 16
2024/2025773 65 203 123 127 160 93 2 0 0 0 0 0
Totale 5.326